HEDIS® Results
Medicare HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
|
Measure |
2023 Rate |
2023 Goal |
2024 Rate |
2024 Goal |
|
Breast Cancer Screening (BCS) |
55.26% |
71.00% |
|
|
|
Breast Cancer Screening (BCS-E) |
|
|
53.66% |
78.57% |
|
Care for Older Adults - Medication Review (COA) |
48.57% |
93.00% |
NQ |
87.00% |
|
Care for Older Adults - Pain Screening (COA) |
51.43% |
91.00% |
NQ |
90.00% |
|
Colorectal Cancer Screening (COL) |
38.14% |
71.00% |
53.06% |
77.86% |
|
Controlling Blood Pressure (CBP) |
58.54% |
74.00% |
75.95% |
80.65% |
|
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
|
|
72.58% |
77.68% |
|
Diabetes Care - Eye Exam (EED) |
44.44% |
73.00% |
54.84% |
81.03% |
|
Medication Reconciliation Post-Discharge (TRC) |
NA |
68.00% |
33.65% |
84.43% |
|
Osteoporosis Management in Women Who Had a Fracture (OMW) |
NA |
55.00% |
NA |
57.09% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
NA |
88.09% |
81.82% |
88.48% |
Every year, Medicare evaluates plans based on a 5-star rating system. For STAR ratings, please visit [Medicare Plan Finder] or [CMS.gov].
[MLI Taglines required on materials non-small sized only, therefore 8.5x11 paper output include all Multi-Languages taglines located here.]
NA = Not Available
NQ = Not Required
H8845_25_8185_AZHEDISRates_C